A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer
/in Cervical Cancer, Hyperthermia, International Publications /von 2016-08-12 / Int J Hyperthermia 2016 11;32(7):801-8Thermosensitive liposomal cisplatin in combination with local hyperthermia results in tumor growth delay and changes in tumor microenvironment in xenograft models of lung carcinoma
/in Hyperthermia, International Publications, NSCLC /von 2016-06-16 / J Drug Target 2016 11;24(9):865-877Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2016-06-13 / Cell Death Discov 2016;2:16039Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma
/in Hepatocellular Carcinoma, Hyperthermia, International Publications /von 2016-06-07 / Int J Hyperthermia 2016 09;32(6):648-56Immune effects by selective heating of membrane rafts of cancer-cells.
/in Hyperthermia, International Publications /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14571)In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-05-14 / Cancers (Basel) 2016 May;8(5)Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
/in Hyperthermia, International Publications /von 2016-04-29 / Front Immunol 2016;7:171Improving efficacy of hyperthermia in oncology by exploiting biological mechanisms
/in Hyperthermia, International Publications /von 2016-04-18 / Int J Hyperthermia 2016 06;32(4):446-54Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-44
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de